Is the emperor wearing clothes?: Clinical trials of vitamin E and the LDL oxidation hypothesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 8, 2001, Pages 1261-1264

  Heinecke, Jay W ^a  

^a Division of Atherosclerosis   (United States)

Author keywords

Antioxidant; Atherosclerosis; Lipid peroxidation; Oxidative stress; Oxidized LDL

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CLINICAL TRIAL; DRUG EFFECT; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

EID: 0035573705     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0801.095084     Document Type: Short Survey

References (44)

1. Role of oxidized low density lipoprotein in atherogenesis
2. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
3. The yin and yang of oxidation in the development of the fatty streak: A review based on the 1994 George Lyman Duff memorial lecture
4. Antioxidants and atherosclerotic heart disease
5. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low density lipoprotein hypothesis
6. The oxidation of lipoproteins by monocytes-macrophages: Biochemical and biological mechanisms
7. The ambivalence of vitamin E in atherogenesis
8. Probucol inhibits oxidative modification of low density lipoprotein
9. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture
10. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N-diphenyl-phenylenediamine
11. Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
12. The antioxidant butylated hydroxytoluene protects against atherosclerosis
13. Inhibition of hypercholesterolemia-induced atherosclerosis in nonhuman primate by probucol, I: Is the extend of atherosclerosis related to resistance of LDL to oxidation?
14. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits
15. Antioxidants as anti-atherogens: Animal studies
16. Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice
17. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice
18. The isoprostanes: Current knowledge and directions for future research
19. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease
20. Increased atherosclerosis in hyperlipidemic mice deficient in alpha-tocopherol transfer protein and vitamin E
21. The effect of alpha-tocopherol on monocyte proatherogenic activity
22. Is there a vitamin E paradox?
23. Vitamin E as an in vitro and in vivo antioxidant
24. Vitamin E in human low density lipoprotein: When and how this antioxidant becomes a pro-oxidant
25. Vitamin E consumption and the risk of coronary disease in women
26. Vitamin E consumption and the risk of coronary heart disease in men
27. Bioavailability and potency of natural-source and all-racemic alpha-tocopherol in the human: A dispute
28. Comparison of supplementation of RRR-alpha-tocopherol and racemic alpha-tocopherol in humans: Effects on lipid levels and lipoprotein susceptibility to oxidation
29. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
30. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial: Gruppo Italiano per lo studio della sopravvivenza nell'infarto miocardico
31. GISSI-Prevenzione trial
32. Vitamin E supplementation and cardiovascular events in high-risk patients: The heart outcomes prevention evaluation study investigators
33. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers: The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group
34. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial
35. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications
36. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids
37. In vivo formation of 8-epi-prostaglandin F2 alpha is increased in hypercholesterolemia
38. Effects of vitamin E on lipid peroxidation in healthy persons
39. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers
40. Ongoing prothrombotic state in patients with antiphospholipid antibodies: A role for increased lipid peroxidation
41. 2α and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation
42. Mass spectrometric quantification of amino acid oxidation products in proteins: Insights into pathways that promote LDL oxidation in the human artery wall
43. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein
44. Alpha-tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein